Retrospective cohort study of hospitalized adults treated with vancomycin or clindamycin for methicillin-resistant Staphylococcus aureus skin infections

Clinical Therapeutics

Volumn 32, Issue 12, 2010, Pages 2024-2029

  Frei, Christopher R ^a,b   Miller, Monica L ^a,b,c   Lewis, James S ^b,d   Lawson, Kenneth A ^a   Peddaiahgari, Rajesh ^a   Talbert, Robert L ^a,b  

^a UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c PURDUE UNIVERSITY   (United States)

^d UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Antibiotic; Hospital; Methicillin resistant Staphylococcus aureus; MRSA; Outcomes; Resistance; Skin infection

Indexed keywords

CIPROFLOXACIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL SKIN DISEASE; DRUG TREATMENT FAILURE; FEMALE; HISPANIC; HOSPITAL PATIENT; HUMAN; INCISION; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; RETROSPECTIVE STUDY; SURGICAL DRAINAGE; TREATMENT OUTCOME;

ADULT; ANTI-BACTERIAL AGENTS; CLINDAMYCIN; HOSPITALS, UNIVERSITY; HUMANS; INPATIENTS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL SKIN INFECTIONS; VANCOMYCIN;

EID: 78649531422     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2010.11.004     Document Type: Article

References (23)

1. Levine DP Vancomycin: A history. Clin Infect Dis. 2006, 42(Suppl 1):S5-S12.
2. Diep BA, Carleton HA, Chang RF, et al. Roles of 34 virulence genes in the evolution of hospital- and communityassociated strains of methicillin-resistant Staphylococcus aureus. J Infect Dis. 2006, 193:1495-1503.
3. Naimi TS, LeDell KH, Como-Sabetti K, et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA. 2003, 290:2976-2984.
4. LaPlante KL, Rybak MJ, Amjad M, Kaatz GW Antimicrobial susceptibility and staphylococcal chromosomal cassette mec type in communityand hospital-associated methicillinresistant Staphylococcus aureus. Pharmacotherapy. 2007, 27:3-10.
5. Tsuji BT, Rybak MJ, Cheung CM, et al. Community- and health careassociated methicillin-resistant Staphylococcus aureus: A comparison of molec- ular epidemiology and antimicrobial activities of various agents. Diagn Microbiol Infect Dis. 2007, 58:41-47.
6. Hyun DY, Mason EO, Forbes A, Kaplan SL Trimethoprim-sulfamethoxazole or clindamycin for treatment of community-acquired methicillinresistant Staphylococcus aureus skin and soft tissue infections. Pediatr Infect Dis J. 2009, 28:57-59.
7. Barnes EV, Dooley DP, Hepburn MJ, Baum SE Outcomes of communityacquired, methicillin-resistant Staphylococcus aureus, soft tissue infections treated with antibiotics other than vancomycin. Mil Med. 2006, 171:504-507.
8. Drekonja DM, Traynor LM, DeCarolis DD, et al. Treatment of non-life-threatening methicillin-resistant Staphyloccus aureus with alternative antimicrobial agents: A 2-year retrospective review. Diagn Microbiol Infect Dis. 2009, 63:201-207.
9. Stevens DL, Bisno AL, Chambers HF Practice guidelines for the diagnosis and management of skin and soft-tissue infections [published correction appears in Clin Infect Dis. 2006;42:1219]. Clin Infect Dis. 2005, 41:1373-1406. Infectious Diseases Society of America.
10. Moran GJ, Krishnadasan A, Gorwitz RJ, Methicillin-resistant S, et al. aureus infections among patients in the emergency department. N Engl J Med. 2006, 355:666-674. EMERGEncy ID Net Study Group.
11. Meislin HW, Lerner SA, Graves MH, et al. Cutaneous abscesses. Anaerobic and aerobic bacteriology and outpatient management. Ann Intern Med. 1977, 87:145-149.
12. Miller LG, Quan C, Shay A, et al. A prospective investigation of out- comes after hospital discharge for endemic, community-acquired methicillin-resistant and -susceptible Staphylococcus aureus skin infection. Clin Infect Dis. 2007, 44:483-492.
13. Fridkin SK, Hageman JC, Morrison M, et al. Methicillin-resistant Staphylococcus aureus disease in three communities [published correction appears in N Engl J Med. 2005;352: 2362]. N Engl J Med. 2005, 352:1436-1444. Active Bacterial Core Surveillance Program of the Emerging Infections Program Network.
14. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillinresistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004, 139:947-951.
15. Young DM, Harris HW, Charlebois ED, et al. An epidemic of methicillinresistant Staphylococcus aureus soft tissue infections among medically underserved patients. Arch Surg. 2004, 139:951-953. discussion.
16. Lee NE, Siriarayapon P, Tappero J, et al. Infection control practices for SARS in Lao People's Democratic Republic, Taiwan, and Thailand: Experience from mobile SARS containment teams, 2003. Am J Infect Control. 2004, 32:377-383. SARS Mobile Response Team Investigators.
17. Frank AL, Marcinak JF, Mangat PD, et al. Clindamycin treatment of methicillin-resistant Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2002, 21:530-534.
18. Sattler CA, Mason EO, Kaplan SL Prospective comparison of risk factors and demographic and clinical characteristics of communityacquired, methicillin-resistant versus methicillin-susceptible Staphylococcus aureus infection in children. Pediatr Infect Dis J. 2002, 21:910-917.
19. Siberry GK, Tekle T, Carroll K, Dick J Failure of clindamycin treatment of methicillin-resistant Staphylococcus aureus expressing inducible clindamycin resistance in vitro. Clin Infect Dis. 2003, 37:1257-1260.
20. Hultén KG, Kaplan SL, Gonzalez BE, et al. Three-year surveillance of community onset health careassociated Staphylococcus aureus infections in children. Pediatr Infect Dis J. 2006, 25:349-353.
21. Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL Clindamycin treatment of invasive infections caused by communityacquired, methicillin-resistant and methicillin-susceptible Staphylococcus aureus in children. Pediatr Infect Dis J. 2003, 22:593-598.
22. Mutnick AH, Biedenbach DJ, Turnidge JD, Jones RN Spectrum and potency evaluation of a new oxazolidinone, linezolid: Report from the SENTRY Antimicrobial Surveillance Program, 1998-2000. Diagn Microbiol Infect Dis. 2002, 43:65-73.
23. Fiebelkorn KR, Crawford SA, McElmeel ML, Jorgensen JH Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol. 2003, 41:4740-4744.